@drrobkominiarek's testosterone decline claims, fact-checked
Quick answer
Testosterone replacement therapy involves supplementing testosterone through injections, gels, or patches for men with clinically diagnosed hypogonadism. While population testosterone levels have declined modestly over recent decades, true hypogonadism affects only 2-6% of men and requires both low lab values and clinical symptoms for diagnosis.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
Dr. Rob Kominiarek states that 25-year-old men today have the same testosterone levels as 60-year-old men from the 1980s and 1990s. He also claims testosterone drops about 1% per year and calls this decline a "real pandemic."
The post frames low testosterone as affecting muscle building, mental health, and sexual function. It's clearly marketing testosterone replacement therapy, given the hashtags and incomplete sentence about health consequences.
Is testosterone actually declining?
Yes, but the comparison is overblown. The most comprehensive analysis comes from Travison et al. (Journal of Clinical Endocrinology & Metabolism, 2007), which found testosterone declined 0.4-2.0% per year in American men between 1987-2004.
A Danish study by Andersson et al. (European Journal of Epidemiology, 2007) found similar patterns. However, the "25-year-old equals 60-year-old" comparison isn't supported by specific research. That's likely an exaggeration for social media impact.
The decline is real but varies significantly between studies and populations. Some research suggests it's plateauing in younger generations.
What's driving this decline?
Multiple factors contribute, but it's not the health emergency Kominiarek suggests. Obesity rates explain much of the decline, according to Travison's analysis. Higher BMI directly correlates with lower testosterone.
Other contributors include increased stress, poor sleep, and environmental factors like endocrine disruptors. But calling it a "pandemic" is hyperbolic marketing speak.
Normal aging also accounts for testosterone decline. The Framingham Heart Study found natural drops of 0.4% per year after age 30, which overlaps with the broader population trends.
When is low testosterone actually concerning?
Clinical hypogonadism affects 2-6% of men, depending on age group. The Endocrine Society defines it as total testosterone below 300 ng/dL with symptoms like fatigue, low libido, or mood changes.
Most men don't need testosterone therapy. The American Urological Association's 2018 guidelines recommend TRT only for men with confirmed low levels and symptoms affecting quality of life.
Kominiarek's framing makes normal variation sound pathological. That's problematic because unnecessary TRT carries risks including cardiovascular issues and fertility problems.
What should you actually know?
If you're concerned about low energy or libido, get proper testing. That means multiple morning blood draws, not just one test. Total testosterone, free testosterone, and luteinizing hormone give a complete picture.
Lifestyle changes often help more than hormones. Regular exercise, adequate sleep, and maintaining healthy weight can boost testosterone naturally. The research on this is solid.
Don't let social media doctors convince you that population-level trends apply to your individual health. Most men function perfectly well within the normal range, even if that range has shifted slightly over decades.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @drrobkominiarek's testosterone decline claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@drrobkominiarek's testosterone decline claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy involves supplementing testosterone through injections, gels, or patches for men with clinically diagnosed hypogonadism.
FormBlends verdict
Testosterone replacement therapy involves supplementing testosterone through injections, gels, or patches for men with clinically diagnosed hypogonadism. While population testosterone levels have declined modestly over recent decades, true hypogonadism affects only 2-6% of men and requires both low lab values and clinical symptoms for diagnosis.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy involves supplementing testosterone through injections, gels, or patches for men with clinically diagnosed hypogonadism. While population testosterone levels have declined modestly over recent decades, true hypogonadism affects only 2-6% of men and requires both low lab values and clinical symptoms for diagnosis.
- Population testosterone levels have declined 0.4-2.0% annually since the 1980s according to Travison et al.
- Clinical hypogonadism affects only 2-6% of men and requires both low lab values and symptoms
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Population testosterone levels have declined 0.4-2.0% annually since the 1980s according to Travison et al.
- Clinical hypogonadism affects only 2-6% of men and requires both low lab values and symptoms
- Obesity explains much of the population-level testosterone decline, not environmental toxins
- The comparison between today's 25-year-olds and 1980s 60-year-olds isn't backed by specific research
- Normal aging causes 0.4% annual testosterone decline after age 30 according to the Framingham Heart Study
- Lifestyle changes like exercise and weight loss can boost testosterone naturally
- TRT carries risks including cardiovascular issues and should only be used for confirmed hypogonadism
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rob Kominiarek · Instagram creator
117.4K views on this video
The average 25-year-old male today has the same testosterone levels that 60-year-old men had back in the 80’s and 90’s. Men’s testosterone is dropping approximately 1% per year. The stats speak for t
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rob Kominiarek, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.